| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/15/2004 | WO2004058953A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 07/15/2004 | WO2004058841A2 Synthesis and use of inorganic polymer sensor for detecting nitroaromatic compounds |
| 07/15/2004 | WO2004058823A1 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip |
| 07/15/2004 | WO2004058817A1 Novel proteins and use thereof |
| 07/15/2004 | WO2004058811A2 Crystal structures of yhhf polypeptides |
| 07/15/2004 | WO2004058795A1 Angiogenic compounds and uses thereof |
| 07/15/2004 | WO2004058703A2 Methods of identifying longevity modulators and therapeutic methods of use thereof |
| 07/15/2004 | WO2004058393A2 Method for the validated construction of arrays |
| 07/15/2004 | WO2004058392A2 Intramolecular triplet-sensitized o-nitrophenylethyl photoprotective groups |
| 07/15/2004 | WO2004058391A2 Photoactivatable two-stage protective groups for the synthesis of biopolymers |
| 07/15/2004 | WO2004058325A2 Ion channels as targets for sleep-related drugs |
| 07/15/2004 | WO2004058307A1 Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof |
| 07/15/2004 | WO2004058304A1 Oligosaccharides and conjugates thereof for the treatement of pseudomonas bacteria infection |
| 07/15/2004 | WO2004058292A2 Methods and compositions for suppressing fibrocyte differentiation |
| 07/15/2004 | WO2004058288A1 Novel therapeutic targets in cancer |
| 07/15/2004 | WO2004058287A2 Methods of treating neurological conditions with hematopoeitic growth factors |
| 07/15/2004 | WO2004058185A2 Antiangiogenesis by inhibiting protein kinase ck2 activity |
| 07/15/2004 | WO2004058175A2 Novel use of liver x receptor agonists |
| 07/15/2004 | WO2004058167A2 Breast specific protein expressed in cancer and methods of use thereof |
| 07/15/2004 | WO2004058158A2 Treatment of metastatic cancer with the b-subunit of shiga toxin |
| 07/15/2004 | WO2004058154A2 Method of identifying therapeutic agents |
| 07/15/2004 | WO2004058153A2 Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. |
| 07/15/2004 | WO2004058055A2 Method and system for disease detection using marker combinations |
| 07/15/2004 | WO2004058052A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | WO2004058051A2 Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions |
| 07/15/2004 | WO2004058050A2 Amplified cancer target genes useful in diagnosis and therapeutic screening |
| 07/15/2004 | WO2004058044A2 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 07/15/2004 | WO2004058042A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | WO2004047978A3 1microarrays and production thereof |
| 07/15/2004 | WO2004047853A3 Methods for the treatment of chronic pain and compositions therefor |
| 07/15/2004 | WO2004044221A3 High throughput automatic nucleic acid isolation and quantitation methods |
| 07/15/2004 | WO2004043831A3 Systems and methods of sorting samples |
| 07/15/2004 | WO2004042394A3 Method for providing natural therapeutic agents with high therapeutic index |
| 07/15/2004 | WO2004042391A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) |
| 07/15/2004 | WO2004042387A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) |
| 07/15/2004 | WO2004042386A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) |
| 07/15/2004 | WO2004042363A3 In vivo imaging of e2f-regulated bioluminescent proteins |
| 07/15/2004 | WO2004041865A3 Stabilized single domain antibodies |
| 07/15/2004 | WO2004041863A3 Single domain antibodies directed against interferon- gamma and uses therefor |
| 07/15/2004 | WO2004041076A3 Methods of detecting colorectal cancer |
| 07/15/2004 | WO2004040299A3 Method for identifying compounds which inhibit mechanotransduction in neurons |
| 07/15/2004 | WO2004037848A9 Process for determining target function and identifying drug leads |
| 07/15/2004 | WO2004032708A3 Vasoregulating compounds and methods of their use |
| 07/15/2004 | WO2004032599A3 Novel immunogenic proteins of leptospira |
| 07/15/2004 | WO2004031752A3 An infrared measuring apparatus and method for on-line application in manufacturing processes |
| 07/15/2004 | WO2004031412A3 Method for diagnosing pancreatic cancer |
| 07/15/2004 | WO2004029616A3 Methods for detecting prostate cancer |
| 07/15/2004 | WO2004029280A3 Anti-hla assay and methods |
| 07/15/2004 | WO2004024879A3 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 07/15/2004 | WO2004023146A3 Methods for assaying protein-protein interactions |
| 07/15/2004 | WO2004023097A3 Homocysteine assay adaptable to screening |
| 07/15/2004 | WO2004022713A3 Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
| 07/15/2004 | WO2004022006A3 Methods of diagnosing cervical cancer |
| 07/15/2004 | WO2004014296A3 Method of detecting and preventing alzheimer’s disease, particularly at prodromal and early stages |
| 07/15/2004 | WO2004012847A9 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers |
| 07/15/2004 | WO2004012231A3 Method and apparatus for control of mobility-based ion species identification |
| 07/15/2004 | WO2004011905A3 Quality assurance/quality control for electrospray ionization processes |
| 07/15/2004 | WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 07/15/2004 | WO2004001421A3 Method for the diagnosis and differential diagnosis of neurological diseases |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003099209A3 Compositions and methods for screening and identifying anti-hcv agents |
| 07/15/2004 | WO2003098190A3 Protein identification from protein product ion spectra |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003091664A3 Test for brake fluid age and condition |
| 07/15/2004 | WO2003087391A3 Hydrophobic zone device |
| 07/15/2004 | WO2003083905A3 Novel integrated circuit chip for bioassays_____________________ |
| 07/15/2004 | WO2003076929A3 Method for the evaluation of velvet antler |
| 07/15/2004 | WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003051912A9 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2003042395B1 Programmable and autonomous computing machine made of biomolecules |
| 07/15/2004 | WO2003035839A3 Target specific screening andits use for identifying target binders |
| 07/15/2004 | WO2002097112A3 Catalytic amplification of multiplexed assay signals |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | WO2002072811A3 Human prenylcysteine lyase-like protein |
| 07/15/2004 | US20040139487 Transgenic animal and uses thereof |
| 07/15/2004 | US20040139486 Interstitial prostatism model animal |
| 07/15/2004 | US20040138840 Method for remote monitoring of water treatment systems |
| 07/15/2004 | US20040138830 Method for calculating physical properties, physical properties calculating apparatus, and computer program product |
| 07/15/2004 | US20040138824 Linkage analysis using direct and indirect counting |
| 07/15/2004 | US20040138823 Personal breath tester |
| 07/15/2004 | US20040138821 System, method, and computer software product for analysis and display of genotyping, annotation, and related information |
| 07/15/2004 | US20040138820 Method to control body weight |
| 07/15/2004 | US20040138542 Systems and methods of pH tissue monitoring |
| 07/15/2004 | US20040138446 Biotin derivative with ether, amide or amine group for detection of drug interactions. |
| 07/15/2004 | US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 07/15/2004 | US20040138420 Fluorescent proteins |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138250 Inhibitors of cruzipain and other cysteine proteases |
| 07/15/2004 | US20040138189 Moderation of intracellular signals; antitumor agents; drug screening; administering cucurbitacin compound |
| 07/15/2004 | US20040138169 Competitive binding with enzyme involved in metabolism of homoocysteine; permeability of erythrocyte membrane; enzyme inhibitor |
| 07/15/2004 | US20040138161 Methods of modulating proliferative conditions |
| 07/15/2004 | US20040138153 enzyme inhibitors; drug screening |
| 07/15/2004 | US20040138114 nucleotide sequences codes for polypeptide used for diagnosis and prophylaxis of autoimmune diseases |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |